IDEAYA Biosciences, Inc. - Common Stock (IDYA)

CUSIP: 45166A102

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock
Shares outstanding
87,836,000
Total 13F shares
44,731,101
Share change
+9,133,011
Total reported value
$667,335,427
Price per share
$14.92
Number of holders
111
Value change
+$139,348,641
Number of buys
73
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Logos Global Management LP
13F
Company
4.3%
3,750,000
$51,750,000 30 Jun 2022
13F
Avidity Partners Management LP
13F
Company
3.4%
2,972,947
$41,027,000 30 Jun 2022
13F
BVF INC/IL
13F
Company
3.2%
2,794,859
$38,569,000 30 Jun 2022
13F
Canaan Partners X LLC
13F
Company
3%
2,660,713
$36,718,000 30 Jun 2022
13F
BlackRock Finance, Inc.
13F
Company
3%
2,622,288
$36,188,000 30 Jun 2022
13F
Boxer Capital, LLC
13F
Company
2.5%
2,202,812
$30,399,000 30 Jun 2022
13F
FEDERATED HERMES, INC.
13F
Company
2.5%
2,162,091
$29,837,000 30 Jun 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.1%
1,886,252
$26,030,000 30 Jun 2022
13F
VANGUARD GROUP INC
13F
Company
2%
1,752,841
$24,189,000 30 Jun 2022
13F
Point72 Asset Management, L.P.
13F
Company
1.7%
1,509,000
$20,824,000 30 Jun 2022
13F
STATE STREET CORP
13F
Company
1.7%
1,482,154
$20,454,000 30 Jun 2022
13F
5AM Venture Management, LLC
13F
Company
1.6%
1,398,066
$19,293,000 30 Jun 2022
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
1.1%
923,044
$12,738,000 30 Jun 2022
13F
Alphabet Inc.
13F
Company
0.86%
753,187
$10,394,000 30 Jun 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.82%
721,044
$9,950,000 30 Jun 2022
13F
FMR LLC
13F
Company
0.71%
625,223
$8,628,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.7%
619,168
$8,544,000 30 Jun 2022
13F
DAFNA Capital Management LLC
13F
Company
0.62%
548,561
$7,570,000 30 Jun 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.57%
496,729
$6,854,000 30 Jun 2022
13F
AXA S.A.
13F
Company
0.49%
427,248
$5,896,022 30 Jun 2022
13F
NORTHERN TRUST CORP
13F
Company
0.37%
328,651
$4,535,000 30 Jun 2022
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.34%
296,167
$4,087,000 30 Jun 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.28%
245,806
$3,392,000 30 Jun 2022
13F
Michael P. Dillon
3/4/5
SVP, Chief Scientific Officer
mixed-class rows
102,226
mixed-class rows
$3,311,116 04 Oct 2021
CITIGROUP INC
13F
Company
0.23%
203,498
$2,808,000 30 Jun 2022
13F
ACT CAPITAL MANAGEMENT, LLC
13F
Company
0.2%
173,500
$2,394,000 30 Jun 2022
13F
HighVista Strategies LLC
13F
Company
0.15%
130,380
$1,799,000 30 Jun 2022
13F
Bank of New York Mellon Corp
13F
Company
0.12%
108,529
$1,498,000 30 Jun 2022
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.12%
104,401
$1,441,000 30 Jun 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.11%
100,991
$1,394,000 30 Jun 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.11%
99,982
$1,380,000 30 Jun 2022
13F
Ensign Peak Advisors, Inc
13F
Company
0.11%
94,781
$1,308,000 30 Jun 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.1%
90,819
$1,254,000 30 Jun 2022
13F
MORGAN STANLEY
13F
Company
0.1%
86,046
$1,186,000 30 Jun 2022
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.07%
64,478
$889,000 30 Jun 2022
13F
Swiss National Bank
13F
Company
0.07%
63,800
$880,000 30 Jun 2022
13F
JACOB ASSET MANAGEMENT OF NEW YORK LLC
13F
Company
0.06%
55,134
$761,000 30 Jun 2022
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.06%
54,778
$756,000 30 Jun 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
54,282
$749,000 30 Jun 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.06%
50,007
$690,000 30 Jun 2022
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.05%
44,549
$617,165 30 Jun 2022
13F
Rafferty Asset Management, LLC
13F
Company
0.05%
44,167
$610,000 30 Jun 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.05%
44,100
$609,000 30 Jun 2022
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
38,155
$527,000 30 Jun 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.04%
33,943
$468,000 30 Jun 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.03%
26,207
$362,000 30 Jun 2022
13F
SG Americas Securities, LLC
13F
Company
0.03%
24,876
$343,000 30 Jun 2022
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.03%
24,372
$336,000 30 Jun 2022
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.03%
23,083
$319,000 30 Jun 2022
13F
ALPS ADVISORS INC
13F
Company
0.03%
22,925
$316,000 30 Jun 2022
13F

Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q3 2022

As of 30 Sep 2022, IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,731,101 shares. The largest 10 holders included Logos Global Management LP, Avidity Partners Management LP, BVF INC/IL, FEDERATED HERMES, INC., BlackRock Inc., Canaan Partners X LLC, BOXER CAPITAL, LLC, VANGUARD GROUP INC, STATE STREET CORP, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 111 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
95
Q3 2022 holders
111
Holder diff
16
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .